Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study.
Dina R KhasanovaMikhail N KalininPublished in: BMC neurology (2023)
ISRCTN87656744 . Trial Registration Date: 16/02/2021.